Topics
May/June 2026 | Letter to the Editors - Online Exclusive
Beyond One-Size-Fits-All: The Move Toward Personalized Vitreoretinal Therapy
By calculating the vitreous volume exact, clinicians can treat eyes with greater precision.
Andreas F. Borkenstein, MD
October 9, 2026
Perceive Bio Completes Phase 2a Enrollment in VOY-101 Gene Therapy Study for Geographic Atrophy
Haag-Streit Launches Eyesi Surgical 3.0 Virtual Reality Training Platform at AAO
October 7, 2026
Atsena Reports Preliminary ATSN-201 Results in X-linked Retinoschisis
Study Links GLP-1 Use to Earlier Fellow-Eye NAION Involvement
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
